ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Selexis, Teneobio Enter Second Services Agreement
contractpharma
December 21, 2018Selexis SA?and?Teneobio, Inc.?have entered into a second services agreement to expand Teneobio’s oncology pipeline of Human Heavy-Chain Antibodies (UniAbs), a new class of multi-specific biologics. Teneobio will utilize Selexis’ SUREtechnology?Platform -
Alvotech, Fuji Pharma Expand Biosimilars Alliance
contractpharma
December 19, 2018Alvotech?and?Fuji Pharma?have entered an exclusive agreement for the development and commercialization of biosimilars in Japan. Fuji is acquiring a 4.2% stake in Alvotech for approximately $50 million
Pharma Sources Insight January 2025
